DO M2-MUSCARINIC RECEPTORS CONTRIBUTE TO HUMAN BLADDER FUNCTION IN VIVO?

2009 ◽  
Vol 181 (4) ◽  
pp. 570-571 ◽  
Author(s):  
Martin C Michel ◽  
Romana Pahladsingh ◽  
Christine A Teitsma ◽  
Frank Baas ◽  
Jean de la Rosette
2009 ◽  
Vol 8 (4) ◽  
pp. 177
Author(s):  
M.C. Michel ◽  
R. Pahladsingh ◽  
C.A. Teitsma ◽  
F. Baas ◽  
J.J.M.C.H. De La Rosette

1991 ◽  
Vol 554 (1-2) ◽  
pp. 329-332 ◽  
Author(s):  
JoséL. Góngora-Alfaro ◽  
Salvador Hernández-López ◽  
Daniel Martínez-Fong ◽  
Jean-Louis Brassart ◽  
Jorge Aceves

2006 ◽  
Vol 175 (4S) ◽  
pp. 417-417
Author(s):  
Shachi Tyagi ◽  
Naoki Yoshimura ◽  
Michael B. Chancellor ◽  
Fernando De Miguel

Toxicology ◽  
1994 ◽  
Vol 93 (2-3) ◽  
pp. 99-112 ◽  
Author(s):  
S. Schulte ◽  
W.E. Müller ◽  
K.D. Friedberg

1979 ◽  
Vol 168 (1) ◽  
pp. 216-218 ◽  
Author(s):  
Britta Hedlund ◽  
Marilena Gamarra ◽  
Tamas Bartfai
Keyword(s):  

1992 ◽  
Vol 12 (4) ◽  
pp. 562-570 ◽  
Author(s):  
Hans W. Müller-Gärtner ◽  
Alan A. Wilson ◽  
Robert F. Dannals ◽  
Henry N. Wagner ◽  
J. James Frost

A method to image muscarinic acetylcholine receptors (muscarinic receptors) noninvasively in human brain in vivo was developed using [123I]4-iododexetimide ([123I]IDex), [123I]4-iodolevetimide ([123I]ILev), and single photon emission computed tomography (SPECT). [123I]IDex is a high-affinity muscarinic receptor antagonist. [123I]ILev is its pharmacologically inactive enantiomer and measures nonspecific binding of [123I]IDex in vitro. Regional brain activity after tracer injection was measured in four young normal volunteers for 24 h. Regional [123I]IDex and [123I]ILev activities were correlated early after injection, but not after 1.5 h. [123I]IDex activity increased over 7–12 h in neocortex, neostriatum, and thalamus, but decreased immediately after the injection peak in cerebellum. [123I]IDex activity was highest in neostriatum, followed in rank order by neocortex, thalamus, and cerebellum. [123I]IDex activity correlated with muscarinic receptor concentrations in matching brain regions. In contrast, [123I]ILev activity decreased immediately after the injection peak in all brain regions and did not correspond to muscarinic receptor concentrations. [123I]IDex activity in neocortex and neostriatum during equilibrium was six to seven times higher than [123I]ILev activity. The data demonstrate that [123I]IDex binds specifically to muscarinic receptors in vivo, whereas [123I]ILev represents the nonspecific part of [123I]IDex binding. Subtraction of [123I]ILev from [123I]IDex images on a pixel-by-pixel basis therefore reflects specific [123I]IDex binding to muscarinic receptors. Owing to its high specific binding, [123I]IDex has the potential to measure small changes in muscarinic receptor characteristics in vivo with SPECT. The use of stereoisomerism directly to measure nonspecific binding of [123I]IDex in vivo may reduce complexity in modeling approaches to muscarinic acetylcholine receptors in human brain.


Sign in / Sign up

Export Citation Format

Share Document